Every SEC Form 3/4/5 on record for this filer (CIK 1774649) — 2 issuers, 16 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| RGEN | REPLIGEN CORP | Director | 2022-05-31 → 2026-05-18 | 6 | — |
| CDAK | Codiak BioSciences, Inc. | Chief Technology Officer · lapsed | 2020-10-13 → 2023-03-30 | 10 | −$192,473 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| CDAK | 2023-03-28 | Sell | 1,932 | $0.20 | $386 | — |
| CDAK | 2023-03-28 | Sell | 7,432 | $0.20 | $1,486 | 1,932 |
| CDAK | 2023-02-17 | Sell | 1,391 | $0.59 | $821 | 7,432 |
| CDAK | 2023-01-20 | Sell | 1,069 | $0.58 | $620 | 1,731 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.